Your browser doesn't support javascript.
loading
Allosterically inhibited PFKL via prostaglandin E2 withholds glucose metabolism and ovarian cancer invasiveness.
Chen, Shengmiao; Wu, Yiran; Gao, Yang; Wu, Chenxu; Wang, Yuetong; Hou, Chun; Ren, Miao; Zhang, Shuyuan; Zhu, Qi; Zhang, Jiali; Yao, Yufeng; Huang, Mei; Qi, Yingchuan B; Liu, Xue-Song; Horng, Tiffany; Wang, Haopeng; Ye, Dan; Zhu, Zhengjiang; Zhao, Suwen; Fan, Gaofeng.
Affiliation
  • Chen S; School of Life Science and Technology, ShanghaiTech University, Shanghai, China.
  • Wu Y; iHuman Institute, ShanghaiTech University, Shanghai, China.
  • Gao Y; Interdisciplinary Research Center on Biology and Chemistry and Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, China.
  • Wu C; School of Life Science and Technology, ShanghaiTech University, Shanghai, China.
  • Wang Y; School of Life Science and Technology, ShanghaiTech University, Shanghai, China.
  • Hou C; School of Life Science and Technology, ShanghaiTech University, Shanghai, China.
  • Ren M; School of Life Science and Technology, ShanghaiTech University, Shanghai, China.
  • Zhang S; Shanghai Key Laboratory of Clinical Geriatric Medicine, Huadong Hospital, Fudan University, and Key Laboratory of Metabolism and Molecular Medicine (Ministry of Education), and Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism (Ministry
  • Zhu Q; School of Life Science and Technology, ShanghaiTech University, Shanghai, China.
  • Zhang J; School of Life Science and Technology, ShanghaiTech University, Shanghai, China.
  • Yao Y; School of Life Science and Technology, ShanghaiTech University, Shanghai, China.
  • Huang M; School of Life Science and Technology, ShanghaiTech University, Shanghai, China.
  • Qi YB; School of Life Science and Technology, ShanghaiTech University, Shanghai, China.
  • Liu XS; School of Life Science and Technology, ShanghaiTech University, Shanghai, China.
  • Horng T; School of Life Science and Technology, ShanghaiTech University, Shanghai, China.
  • Wang H; School of Life Science and Technology, ShanghaiTech University, Shanghai, China.
  • Ye D; Shanghai Key Laboratory of Clinical Geriatric Medicine, Huadong Hospital, Fudan University, and Key Laboratory of Metabolism and Molecular Medicine (Ministry of Education), and Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism (Ministry
  • Zhu Z; Interdisciplinary Research Center on Biology and Chemistry and Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, China. Electronic address: jiangzhu@sioc.ac.cn.
  • Zhao S; School of Life Science and Technology, ShanghaiTech University, Shanghai, China; iHuman Institute, ShanghaiTech University, Shanghai, China. Electronic address: zhaosw@shanghaitech.edu.cn.
  • Fan G; School of Life Science and Technology, ShanghaiTech University, Shanghai, China. Electronic address: fangf@shanghaitech.edu.cn.
Cell Rep ; 42(10): 113246, 2023 10 31.
Article in En | MEDLINE | ID: mdl-37831605
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Dinoprostone Limits: Female / Humans Language: En Journal: Cell Rep Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Dinoprostone Limits: Female / Humans Language: En Journal: Cell Rep Year: 2023 Document type: Article Affiliation country: Country of publication: